{
    "id": 25709,
    "fullName": "BAP1 mutant",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "BAP1 mutant indicates an unspecified mutation in the BAP1 gene.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "category",
    "gene": {
        "id": 8314,
        "geneSymbol": "BAP1",
        "terms": [
            "BAP1",
            "HUCEP-13",
            "hucep-6",
            "UCHL2"
        ]
    },
    "variant": "mutant",
    "createDate": "11/02/2016",
    "updateDate": "11/02/2016",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 9104,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, treatment with GSK126 resulted in increased E-Cadherin expression and decreased invasion of a BAP1-mutant mesothelioma cells in culture (PMID: 26437366).",
            "molecularProfile": {
                "id": 26741,
                "profileName": "BAP1 mutant"
            },
            "therapy": {
                "id": 2925,
                "therapyName": "GSK126",
                "synonyms": null
            },
            "indication": {
                "id": 1790,
                "name": "malignant mesothelioma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 6916,
                    "pubMedId": 26437366,
                    "title": "Loss of BAP1 function leads to EZH2-dependent transformation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26437366"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 19295,
            "approvalStatus": "Guideline",
            "evidenceType": "Risk Factor",
            "efficacyEvidence": "Germline BAP1 mutations are associated with increased risk of developing uveal melanoma, and BAP1 mutations are associated with high risk of developing distant metastasis (NCCN.org).",
            "molecularProfile": {
                "id": 26741,
                "profileName": "BAP1 mutant"
            },
            "therapy": {
                "id": 1776,
                "therapyName": "N/A",
                "synonyms": null
            },
            "indication": {
                "id": 6039,
                "name": "uveal melanoma",
                "source": "DOID"
            },
            "responseType": "not applicable",
            "references": [
                {
                    "id": 10889,
                    "pubMedId": null,
                    "title": "NCCN.org",
                    "url": "https://www.nccn.org/professionals/physician_gls/default.aspx"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        },
        {
            "id": 9103,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, BAP1-mutant mesothelioma cell lines demonstrated increased sensitivity to EPZ011989 in culture compared to BAP1 wild-type cell lines, and EPZ011989 inhibited tumor growth and metastasis in BAP1-mutant mesothelioma cell line xenograft models (PMID: 26437366).",
            "molecularProfile": {
                "id": 26741,
                "profileName": "BAP1 mutant"
            },
            "therapy": {
                "id": 2926,
                "therapyName": "EPZ011989",
                "synonyms": null
            },
            "indication": {
                "id": 1790,
                "name": "malignant mesothelioma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 6916,
                    "pubMedId": 26437366,
                    "title": "Loss of BAP1 function leads to EZH2-dependent transformation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26437366"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 10432,
            "approvalStatus": "Phase II",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase II trial, BAP1 mutations were associated with shorter first-line progression free survival (4.9 vs 10.5 months) in first-line Afinitor (everolimus)-treated renal cell carcinoma patients compared to first-line Sutent (sunitinib)-treated patients (PMID: 27751729).",
            "molecularProfile": {
                "id": 26741,
                "profileName": "BAP1 mutant"
            },
            "therapy": {
                "id": 735,
                "therapyName": "Everolimus",
                "synonyms": null
            },
            "indication": {
                "id": 4450,
                "name": "renal cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 8445,
                    "pubMedId": 27751729,
                    "title": "Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27751729"
                }
            ],
            "ampCapAscoEvidenceLevel": "B",
            "ampCapAscoInferredTier": "I"
        }
    ],
    "molecularProfiles": [
        {
            "id": 26741,
            "profileName": "BAP1 mutant",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}